Thermo Fisher Scientific Inc.

NYSE TMO

Thermo Fisher Scientific Inc. Market Capitalization on October 14, 2024: USD 230.65 B

Thermo Fisher Scientific Inc. Market Capitalization is USD 230.65 B on October 14, 2024, a 20.97% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Thermo Fisher Scientific Inc. 52-week high Market Capitalization is USD 240.46 B on September 10, 2024, which is 4.25% above the current Market Capitalization.
  • Thermo Fisher Scientific Inc. 52-week low Market Capitalization is USD 168.36 B on October 27, 2023, which is -27.00% below the current Market Capitalization.
  • Thermo Fisher Scientific Inc. average Market Capitalization for the last 52 weeks is USD 214.90 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
NYSE: TMO

Thermo Fisher Scientific Inc.

CEO Mr. Marc N. Casper
IPO Date March 17, 1980
Location United States
Headquarters 168 Third Avenue
Employees 122,000
Sector Health Care
Industries
Description

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Similar companies

IDXX

IDEXX Laboratories, Inc.

USD 478.01

0.36%

ILMN

Illumina, Inc.

USD 149.07

2.43%

RVTY

Revvity, Inc.

USD 122.91

1.15%

GH

Guardant Health, Inc.

USD 21.35

-0.23%

CRL

Charles River Laboratories International, Inc.

USD 193.15

0.09%

WAT

Waters Corporation

USD 357.59

-0.11%

A

Agilent Technologies, Inc.

USD 144.25

0.30%

MTD

Mettler-Toledo International Inc.

USD 1.46 K

0.41%

DHR

Danaher Corporation

USD 271.56

0.46%

StockViz Staff

October 16, 2024

Any question? Send us an email